Literature DB >> 12742883

Infant sleep position and associated health outcomes.

Carl E Hunt1, Samuel M Lesko, Richard M Vezina, Rosha McCoy, Michael J Corwin, Frederick Mandell, Marian Willinger, Howard J Hoffman, Allen A Mitchell.   

Abstract

BACKGROUND: The incidence of sudden infant death syndrome has decreased in the United States as the percentage of infants sleeping prone has decreased, but persisting concerns about the safety of supine sleeping likely contribute to prone sleeping prevalence rates that remain higher than 10%.
OBJECTIVE: To document health outcomes in infants aged 1 to 6 months in relation to sleep position.
DESIGN: Prospective cohort study.
SETTING: Massachusetts and Ohio, from February 21, 1995, to December 31, 1998. STUDY PARTICIPANTS: A total of 3733 infants with consistent sleep positions at ages 1, 3, and 6 months. MAIN OUTCOME MEASURES: Descriptive statistics and multiple logistic regression analysis relating sleep position at each follow-up age to symptoms in the prior week (fever, cough, wheezing, stuffy nose, trouble breathing or sleeping, diarrhea, vomiting, or spitting up) and outpatient visits in the prior month (ear infection, breathing problem, vomiting, spitting up, colic, seizure, accident, or injury).
RESULTS: No symptoms or outpatient visits were significantly more common among infants sleeping on the side or supine than in infants sleeping prone, and 3 symptoms were less common: (1) fever at 1 month in infants sleeping in the supine (adjusted odds ratio [OR], 0.56; 95% confidence interval [CI], 0.34-0.93) and side positions (OR, 0.48; 95% CI, 0.28-0.82); (2) stuffy nose at 6 months in the supine (OR, 0.74; 95% CI, 0.61-0.89) and side positions (OR, 0.82; 95% CI, 0.68-0.99); and (3) trouble sleeping at 6 months in the supine (OR, 0.57; 95% CI, 0.44-0.73) and side positions (OR, 0.69; 95% CI, 0.53-0.89). Also, outpatient visits for ear infections were less common at 3 and 6 months in infants sleeping in the supine position (OR, 0.64; 95% CI, 0.46-0.88; and OR, 0.73; 95% CI, 0.58-0.92, respectively) and at 3 months in the side position (OR, 0.68; 95% CI, 0.49-0.96).
CONCLUSIONS: No identified symptom or illness was significantly increased among nonprone sleepers during the first 6 months of life. These reassuring results may contribute to increased use of the supine position for infant sleeping.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742883     DOI: 10.1001/archpedi.157.5.469

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  7 in total

1.  First-time mothers' selection of infant supine sleep positioning.

Authors:  Mary Catherine Goetter; Mary Beth Flanders Stepans
Journal:  J Perinat Educ       Date:  2005

2.  Early otitis media among Minnesota American Indians: the Little Ears Study.

Authors:  Kathleen A Daly; Phyllis L Pirie; Kristine L Rhodes; Lisa L Hunter; Cynthia S Davey
Journal:  Am J Public Health       Date:  2006-12-28       Impact factor: 9.308

Review 3.  Sudden infant death syndrome.

Authors:  Carl E Hunt; Fern R Hauck
Journal:  CMAJ       Date:  2006-06-20       Impact factor: 8.262

4.  Maternal smoking and sudden infant death syndrome: epidemiological study related to pathology.

Authors:  Luigi Matturri; Giulia Ottaviani; Anna Maria Lavezzi
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

5.  Effect of sleep position in term healthy newborns on sudden infant death syndrome and other infant outcomes: A systematic review.

Authors:  Mayank Priyadarshi; Bharathi Balachander; Mari J Sankar
Journal:  J Glob Health       Date:  2022-07-16       Impact factor: 7.664

Review 6.  Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia.

Authors:  Anu Thukral; Ashok Deorari; Deepak Chawla
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

7.  Risk factors for failing the hearing screen due to otitis media in Dutch infants.

Authors:  Willeke Lok; Lucien J C Anteunis; Cor Meesters; Michelene N Chenault; Mark P Haggard
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-30       Impact factor: 2.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.